Kitas, George D <br/><br/>
A Multicenter, Randomized, Placebo-Controlled Trial of Atorvastatin for the Primary Prevention of Cardiovascular Events in Patients With Rheumatoid Arthritis.  [electronic resource] 

 -  Arthritis & rheumatology (Hoboken, N.J.)  09 2019 
 - 1437-1449 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2326-5205 
<br/><br/><label>Standard No.: </label>10.1002/art.40892  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Anticholesteremic Agents--therapeutic use<br/>Arthritis, Rheumatoid--blood<br/>Atorvastatin--therapeutic use<br/>Cardiovascular Diseases--etiology<br/>Cholesterol, LDL--blood<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Primary Prevention--methods<br/>Proportional Hazards Models<br/>Treatment Outcome